ethyl 1-cyclopentyl-2-(4-hydroxy)phenyl-1H-benzimidazole-5-carboxylate | 885312-84-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: ethyl 1-cyclopentyl-2-(4-hydroxy)phenyl-1H-benzimidazole-5-carboxylate
• CAS: 885312-84-5
• 化学式: C₂₁H₂₂N₂O₃
• 分子量: 350.417
• InChiKey: IBMVEBXHPJDWCI-UHFFFAOYSA-N

物化性质

• 沸点：
  562.5±56.0 °C(Predicted)
• 密度：
  1.28±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  26.0
• 可旋转键数：
  4.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  64.35
• 氢给体数：
  1.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  ethyl 1-cyclopentyl-2-(4-hydroxy)phenyl-1H-benzimidazole-5-carboxylate 在 sodium hydroxide 、 potassium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 2-[4-(4-chlorobenzyloxy)phenyl]-1-cyclopentylbenzimidazole-5-carboxylic acid
  参考文献：
  名称：

  Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole

  摘要：

  A series of 1-cycloalkyl-2-phenyl-1H-benzimidazole-5-carboxylic acid derivatives was synthesized and evaluated for inhibitory activity against HCV NS5B RNA-dependent RNA polymerase (RdRp). A SAR study was performed and led to identify the 2-[(4-diarylmethoxy)phenyl]-benzimidazoles as potent inhibitors. They inhibit subgenomic HCV RNA replication in the replicon cells at low micromolar concentrations (EC50 as low as 1.1 mu M). They are selective against. DNA polymerases (IC50 > 10 mu M) and exhibit low cytotoxicity. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.032
• 作为产物：
  描述：

  4-氟-3-硝基苯甲酸乙酯 在 palladium on activated charcoal 吡啶 、 4-二甲氨基吡啶 、 氢气 、 potassium carbonate 、 溶剂黄146 作用下， 以 乙醇 、 二氯甲烷 、 二甲基亚砜 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 4.0h， 生成 ethyl 1-cyclopentyl-2-(4-hydroxy)phenyl-1H-benzimidazole-5-carboxylate
  参考文献：
  名称：

  Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole

  摘要：

  A series of 1-cycloalkyl-2-phenyl-1H-benzimidazole-5-carboxylic acid derivatives was synthesized and evaluated for inhibitory activity against HCV NS5B RNA-dependent RNA polymerase (RdRp). A SAR study was performed and led to identify the 2-[(4-diarylmethoxy)phenyl]-benzimidazoles as potent inhibitors. They inhibit subgenomic HCV RNA replication in the replicon cells at low micromolar concentrations (EC50 as low as 1.1 mu M). They are selective against. DNA polymerases (IC50 > 10 mu M) and exhibit low cytotoxicity. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.032